| Name | Title | Contact Details |
|---|
Medivators, a wholly owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is a leading provider of infection control products and services that ensure the safe and proper disinfection of endoscopes and other devices. Beyond the full line of Medivators medical device reprocessing systems, disinfectants, detergents and other supplies for endoscopy, Medivators also provides sterilants, dialysate concentrates and other supplies for renal dialysis, hollow fiber membrane filtration and separation technologies for medical and non medical applications and liquid chemical germicides and decontamination products and services used in other applications for infection prevention and control. Medivators new low-temperature sterilization service provides superior material compatibility over legacy sterilization methods. Medivators was founded in 1974 and publicly held since 1983 and employs approximately 400 people.
Certified Laboratories is a Plainview, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The employees of SynergEyes are committed to provide the highest quality, technologically advanced hybrid contact lenses that address a wide spectrum of vision conditions, while continuously meeting the needs of today's Practitioner and Patient.
Pediatric Services of America, Inc (PSA Healthcare) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Pediatric Services of America, Inc (PSA Healthcare) is based in Norcross, GA. You can find more information on Pediatric Services of America, Inc (PSA Healthcare) at www.psahealthcare.com
BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.